The effects of low‐dose ketamine on the prefrontal cortex and amygdala in treatment‐resistant depression: A randomized controlled study

Li, Cheng‐Ta, Chen, Mu‐Hong, Lin, Wei‐Chen, Hong, Chen‐Jee, Yang, Bang‐Hung, Liu, Ren‐Shyan, Tu, Pei‐Chi, Su, Tung‐Ping·2016·Human Brain Mapping
DOI 10.1002/hbm.23085

Cited by (153)

Items 101–153 of 153

  1. Prophylactic (R,S)-Ketamine and (2S,6S)-Hydroxynorketamine Decrease Fear Expression by Differentially Modulating Fear Neural Ensembles
    Alessia Mastrodonato, Michelle Jin, Noelle Kee, Marcos Lanio, Juliana Tapia, Liliette Quintana, Andrea Zamora, Shi‐Xian Deng, Xiaoming Xu, Donald W. Landry et al. · 2024 · Biological Psychiatry
  2. Global cognitive dysfunction and β-amyloid neuropathology in late-life and treatment-resistant major depression
    Cheng‐Ta Li, Jong‐Ling Fuh, Bang‐Hung Yang, Chen-Ji Hong, Chi‐Wei Chang, Pei‐Chi Tu, Jia‐Shyun Jeng, Mu‐Hong Chen, Shih‐Jen Tsai, Ya‐Mei Bai et al. · 2021 · Psychological Medicine
  3. Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder
    Joshua O. Willms, Ben McCauley, Lindsay Kerr, Peyton Presto, Ankith Arun, Nazeen Shah, Kierra Irby, Megan Strawn, Jonathan J. Kopel · 2022 · Frontiers in Psychiatry
  4. Ketamine Treatment in Depression: A Systematic Review of Clinical Characteristics Predicting Symptom Improvement
    Darby J. E. Lowe, Daniel J. Müller, Tony Peter George · 2020 · Current Topics in Medicinal Chemistry
  5. Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action
    Madison N. Irwin, Amy VandenBerg · 2021 · Mental Health Clinician
  6. Molecular imaging findings for treatment resistant depression
    Kai‐Chun Yang, Yuan-Hwa Chou · 2023 · Progress in brain research
  7. Low‐dose ketamine infusion in treatment‐resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment‐resistant depression
    Mu‐Hong Chen, Hui-Ju Wu, Cheng‐Ta Li, Wei‐Chen Lin, Shih‐Jen Tsai, Chen‐Jee Hong, Pei‐Chi Tu, Ya‐Mei Bai, Wei‐Chung Mao, Tung‐Ping Su · 2021 · Human Psychopharmacology Clinical and Experimental
  8. Single subanesthetic dose of ketamine produces delayed impact on brain [18F]FDG PET imaging and metabolic connectivity in rats
    Sarah Chaïb, Caroline Bouillot, Sandrine Bouvard, Benjamin Vidal, Luc Zimmer, Elise Levigoureux · 2023 · Frontiers in Neuroscience
  9. Baseline cognitive function predicts full remission of suicidal symptoms among patients with treatment-resistant depression and strong suicidal ideation after low-dose ketamine infusion
    Wei‐Chen Lin, Tung‐Ping Su, Cheng‐Ta Li, Hui-Ju Wu, Shih‐Jen Tsai, Ya‐Mei Bai, Pei‐Chi Tu, Mu‐Hong Chen · 2023 · Journal of Psychopharmacology
  10. Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
    Magdalena Więdłocha, Piotr Marcinowicz, Jan Komarnicki, Małgorzata Tobiaszewska, Weronika Dębowska, Marta Dagmara Dębowska, Agata Szulc · 2024 · Frontiers in Psychiatry
  11. Esketamine-induced post-traumatic stress disorder flashbacks during treatment-resistant depression indication: is it just a side effect?
    Maud Rothärmel, Lila Mékaoui, François Kazour, Morgane Herrero, Eva-Maria Beetz-Lobono, Aistė Lengvenytė, Jérôme Holtzmann, Philippe Raynaud, Macarena Cuenca, Samuel Bulteau et al. · 2024 · medRxiv
  12. Comparative efficacy and safety of intravenous racemic ketamine, repetitive transcranial magnetic stimulation and electroconvulsive therapy for Stage 2 or higher treatment‐resistant depression: A systematic review and network meta‐analysis
    Itsuki Terao, Takahiro Tsuge, Tomoo Sato, Kaori Endo, Kazumasa Kotake, Masahiro Banno, Yuki Kataoka · 2025 · Psychiatry and Clinical Neurosciences Reports
  13. Effects of ketamine on metabolic parameters in depressive disorders: A systematic review
    Sabrina Wong, Gia Han Le, Rodrigo Barbachan Mansur, Joshua Daniel Rosenblat, Angela T.H. Kwan, Kayla M. Teopiz, Roger S. McIntyre · 2024 · Journal of Affective Disorders
  14. Triple-network model–based graph theory analysis of the effectiveness of low-dose ketamine in patients with treatment-resistant depression: two resting-state functional MRI clinical trials
    Wei-Chen Lin, Li‐Kai Cheng, Tung‐Ping Su, Li‐Fen Chen, Pei‐Chi Tu, Cheng‐Ta Li, Ya‐Mei Bai, Shih‐Jen Tsai, Mu‐Hong Chen · 2025 · The British Journal of Psychiatry
  15. Modulating Neuroplasticity: Lessons Learned from Antidepressants and Emerging Novel Therapeutics
    Clarissa G. Yates, Jennifer L. Kruse, J. Blair Price, Avril A. B. Robertson, Susannah J. Tye · 2021 · Current Treatment Options in Psychiatry
  16. Next generation antidepressants with novel mechanisms for treatment resistant depression
    Mu‐Hong Chen, Pei‐Chi Tu, Tung‐Ping Su · 2023 · Progress in brain research
  17. Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysis
    Amin Saberi, Amir Ebneabbasi, Sama Rahimi, Sara Sarebannejad, Zümrüt Duygu Şen, Heiko Graf, Martin Walter, Christian Sorg, Julia A. Camilleri, Angela R. Laird et al. · 2023 · medRxiv
  18. Sex differences in ketamine treatment for depressive disorders: A systematic review
    Ziqin Feng, Hengjin Wu, Fengquan Xu, Yu Zheng, Huazhao Xu · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  19. Intranasal (R)-ketamine modulates depression symptom and neurotransmitters-associated human brain connectivity
    Zhenxiang Zang, Anning Li, Zhifang Zhang, Tingfang Wu, Xiongying Chen, Kaini Qiao, Alimire Paerhati, Zhi Yang, Gang Wang · 2025 · Neurotherapeutics
  20. Ketamine combined with psychotherapy for treatment-resistant depression: Real-world outcomes and the role of subjective experience
    Rebeca Cohen, João Bastos, Catarina Cunha, M. Marguilho, Ana Valle Sancho, Maria João Matos Silva, Franklin King, Pedro Castro-Rodrigues · 2026 · General Hospital Psychiatry
  21. Trauma re-experiencing episodes during esketamine treatment in patients with treatment-resistant depression and comorbid PTSD: a retrospective case series
    Maud Rothärmel, Lila Mékaoui, François Kazour, Morgane Herrero, Eva-Maria Beetz-Lobono, Aistė Lengvenytė, Jérôme Holtzmann, Philippe Raynaud, Macarena Cuenca, Samuel Bulteau et al. · 2026 · European Journal of Psychotraumatology
  22. Ketamine differentially affects implicit and explicit memory processes in rats
    Bahar Yuksel, Zeynep Sen, Güneş Ünal · 2024 · Psychopharmacology
  23. General Anesthetics and Therapeutic Gases
    Joanna Fawkner-Corbett, Alison Hall · 2017 · Side effects of drugs annual
  24. Glucocorticoid receptors mediate reprogramming of astrocytes in depression
    Sedef Dalbeyler, Aleksandra Herud, Bartosz Zglinicki, Patrycja Ziuzia, Marcin Piechota, Dżesika Hoinkis, Laura Bergauer, Carmen Menacho, Zbigniew Sołtys, Pawel Hanus et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  25. A systematic review of ketamine's anxiolytic potential in rodent behavioral models of anxiety and PTSD
    Alena Lemeshova, Kaya A. Patel, Alexander J. Bloom, Lindsay Golan, Haney Haidari, Aiman Limbada, Cherish Zhao, Jennifer A. Honeycutt · 2025 · Pharmacology Biochemistry and Behavior
  26. The Role of Exosomes in the Regulation of Molecular Mechanisms Underlying Treatment Resistance—Linking Cellular Crosstalk to Clinical Implications in Depression
    Kinga Dyndał, Patrycja Pańczyszyn-Trzewik, B. Jakubowska, Magdalena Sowa-Kućma · 2026 · International Journal of Molecular Sciences
  27. Sub‐Anesthetic Ketamine Administration Decreases Deviance Detection Responses at the Cellular, Population‐ and Mesoscale Levels
    Maria Isabel Carreño-Muñoz, Alessandra G. Ciancone Chama, Pegah Chehrazi, Bidisha Chattopadhyaya, Graziella Di Cristo · 2026 · European Journal of Neuroscience
  28. Transcranial Magnetic Stimulation-Derived Motor Parameters and Regional Glucose Metabolism of Motor Cortex
    Cheng‐Ta Li, Chi-Hung Juan · 2016 · Journal of Neurology & Neurophysiology
  29. Efecto de una sola infusión de ketamina sobre síntomas depresivos en pacientes geriátricos sometidos a cirugía oftalmológica: ensayo controlado aleatorizado**
    Dulce María Rascón-Martínez, Ana Fresán, Xóchitl Duque-Alarcón, Ana Carmona-Alvarado, Antonio Castellanos-Olivares, Mario Ulises Pérez‐Zepeda · 2022 · Revista Mexicana de Anestesiología
  30. ATHENA Research Book,Volume 1
    József Györkös, Ron Blonder, Anne Friederike Delouis, Jana Javornik, Konstantinos Petridis · 2022 · University of Maribor, University Press eBooks
  31. Composer-Computer-Interpreter. A Three-way Collaborative Process to the Creation of Two New Works for Multipercussion
    Dimitris Andrikopoulos, Nuno Aroso, ESMAE/IPP-CESEM, Rua da Alegria 503, 4000-045, Porto, Portugal · 2022 · University of Maribor, University Press eBooks
  32. Pain Overview: Classification, Conceptual Framework, and Assessment
    Nuno Duarte, José Ángel García‐Pedraza, Marlene Santos · 2022 · University of Maribor, University Press eBooks
  33. A Pain Physician and Anesthesiologist’s Perspective on Ketamine for Treatment-Resistant Depression
    Lauren E. Gatewood, Andrew W. Gorlin, Christopher H. Bailey, George Barsoum, Steven B. Porter · 2023 · SN Comprehensive Clinical Medicine
  34. A Narrative Review: The Role that Ketamine May Play in the Treatment of Depression and the Underlying Mechanisms of Its Effect
    Sophie Höfels · 2025 · BILT Student Research Journal 2025 - Issue 6
  35. Effects of Adjunctive Ketamine Intravenous Infusion in Taiwanese Patients with Treatment-Resistant Depression: Antidepression, Antisuicidality, BDNF Val66Met, and Brain Imaging
    Mu‐Hong Chen, Tung‐Ping Su · 2020 · Springer eBooks
  36. Ketamine and Other Glutamate Receptor Antagonists As Fast-Actin
    Mu‐Hong Chen, Tung‐Ping Su, Shih‐Jen Tsai · 2022 · Neuromethods
  37. Letter to the Editor: Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis
    Joakim Ekstrand · 2021 · Journal of Affective Disorders
  38. Role of the medial prefrontal cortex in the effects of rapid acting antidepressants on decision-making biases in rodents
    CA Hales, JM Bartlett, R Arban, B Hengerer, ESJ Robinson · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Peripheral biomarkers in Repeated Ketamine Infusions Trial
    Amanda Van Geel · 2021
  40. Tablet Splitting: Influence of Technique and Tablet Format
    Ana Alexandre, Sónia Ferreira, Angelo Miguel Cardoso Jesus · 2022 · University of Maribor, University Press eBooks
  41. Living the Culture through the Commoning
    Daniele Paragano, Giada Semeraro · 2022 · University of Maribor, University Press eBooks
  42. Do Molecular Interventions (Ketamine) Re-establish Synapses in Affected Brain Structures?
    Maxwell R. Bennett · 2024 · Springer eBooks
  43. The role of neuroplasticity in the etiology and treatment of depressive disorders
    Ina Konstantinović, Milena Trandafilović · 2024 · Acta Facultatis Medicae Naissensis
  44. Sub-anesthetic ketamine administration decreases deviance detection responses at the cellular, populational and mesoscale levels
    Maria Isabel Carreño-Muñoz, Alessandra G. Ciancone Chama, Pegah Chehrazi, Bidisha Chattopadhyaya, Graziella Di Cristo · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  45. REWARD – rTMS Effects in Adolescent Depression and Behavioral Addictions
    Johanna K. Loy, Alexander Krieg, Lena Pokorny, Stephan Bender · 2025 · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
  46. Prise en charge médicamenteuse des patients souffrant de douleur chronique réfractaire
    Alexandrine Corriger · 2019 · theses.fr (ABES)
  47. Increase of the AMPA-evoked response of pyramidal neurons in the rat medial prefrontal cortex following acute administration of ketamine and S-ketamine, but not R-ketamine
    Mostafa El Mansari, Naomichi Okamoto, Pierre Blier · 2026 · The International Journal of Neuropsychopharmacology
  48. Shorter to be effective: subanesthetic-dose ketamine infusion reduces the global and regional path length of brain functional connectivity in patients with treatment-resistant depression and suicidal ideation
    Wei‐Chen Lin, Li-Kai Cheng, Tung‐Ping Su, Li-Fen Chen, Pei‐Chi Tu, Cheng‐Ta Li, Ya‐Mei Bai, Shih‐Jen Tsai, Mu‐Hong Chen · 2026 · Psychopharmacology
  49. References
    2024
  50. Cognition-Modulated EEG Signatures and Clinical Features in Major Depressive Disorder: A Machine Learning-Based Exploratory Study
    Cheng‐Ta Li, Chih-An Lai, Jia‐Shyun Jeng, Chih‐Ming Cheng, Ya‐Mei Bai, Chung-Ping Chen · 2026 · ALPHA PSYCHIATRY
  51. Ketamine administration reduced conditioned defensive behaviour and upregulated protein expression associated with neuroplasticity in a planarian model of aversive memory reactivation
    F. E. James, Sayed K. Ahamed, Cheng Yang, Richard Wilson, Juan J. Canales, Carmelo Mario Vicario, Luke R. Johnson, Vanni Caruso · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  52. Low-dose ketamine modulates brain entropy in treatment-resistant depression: Results from two neuroimaging clinical trials
    Ying‐Jay Liou, Li‐Kai Cheng, Wei-Chen Lin, Tung-Ping Su, Li-Fen Chen, Pei‐Chi Tu, Cheng-Ta Li, Ya-Mei Bai, Shih‐Jen Tsai, Mu-Hong Chen · 2026 · Journal of Affective Disorders
  53. BindingDB Entry 50011888: Repurposing of Drugs-The Ketamine Story.
    BindingDB · 2022 · UC San Diego